DSIP
INSUFFICIENT EVIDENCEAlso known as: Delta Sleep-Inducing Peptide
Investigational — not approved for human use
Educational Overview
A nonapeptide first isolated in the 1970s from cerebral venous blood in animal studies, investigated for possible relationships to sleep-phase regulation.
Research Mechanism
Proposed central nervous system activity remains poorly characterised. Published research is sparse and largely dated.
Areas of Study
- Sleep-phase research (preclinical, historical)
Safety Considerations
Human safety is not established. Evidence base is notably thin. Research material only.
Frequently Asked Questions
Is this approved for human use?
No. This material is supplied for laboratory research use only by qualified businesses and institutions. It is not a medicine and is not for human or veterinary consumption.
Do you provide purity documentation?
Certificates of analysis are available to approved accounts. Contact our team for batch-specific documentation.
References
References pending editorial review
We publish citations only after a qualified reviewer has verified them against the primary literature. We do not list references we have not checked. (1 queued.)
Last reviewed: 2026-07-23 · Status: in_review · References verified by editorial review before publication.
Disclaimer: Educational only. Not medical advice, diagnosis, or treatment. For research and educational purposes. Consult a licensed medical professional.